What are the potential risks and side effects of CD19 t-haNK?

This is a question you may want to discuss with your doctor regarding the QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma clinical trial (NCT04052061). Contact the study team or your healthcare provider for specific answers.

How does this treatment compare to my current options?

This is a question you may want to discuss with your doctor regarding the QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma clinical trial (NCT04052061). Contact the study team or your healthcare provider for specific answers.

What will my participation involve in terms of visits and tests?

This is a question you may want to discuss with your doctor regarding the QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma clinical trial (NCT04052061). Contact the study team or your healthcare provider for specific answers.

Are there any specific eligibility criteria I should be aware of?

This is a question you may want to discuss with your doctor regarding the QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma clinical trial (NCT04052061). Contact the study team or your healthcare provider for specific answers.

How will my progress be monitored during the trial?

This is a question you may want to discuss with your doctor regarding the QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma clinical trial (NCT04052061). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma

NCT040520611 siteClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma